CD9 correlates with cancer stem cell potentials in human B-acute lymphoblastic leukemia cells.

[1]  Rob Pieters,et al.  In childhood acute lymphoblastic leukemia, blasts at different stages of immunophenotypic maturation have stem cell properties. , 2008, Cancer cell.

[2]  C. Morimoto,et al.  Stem cell properties and the side population cells as a target for interferon-alpha in adult T-cell leukemia/lymphoma. , 2007, Biochemical and biophysical research communications.

[3]  I. Weissman,et al.  CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia , 2007, Proceedings of the National Academy of Sciences.

[4]  B. Coiffier.  Rituximab therapy in malignant lymphoma , 2007, Oncogene.

[5]  P. Kearns,et al.  Characterization of a progenitor cell population in childhood T-cell acute lymphoblastic leukemia. , 2007, Blood.

[6]  J. Delaissé,et al.  Endothelial cell-driven regulation of CD9 or motility-related protein-1 expression in multiple myeloma cells within the murine 5T33MM model and myeloma patients , 2006, Leukemia.

[7]  J. Dick,et al.  Cancer stem cells: lessons from leukemia. , 2005, Trends in cell biology.

[8]  H. Ikeda,et al.  Down-regulation of CD9 in human ovarian carcinoma cell might contribute to peritoneal dissemination: morphologic alteration and reduced expression of beta1 integrin subsets. , 2005, Cancer research.

[9]  R. Pieters,et al.  Leukemic stem cells in childhood high-risk ALL/t(9;22) and t(4;11) are present in primitive lymphoid-restricted CD34+CD19- cells. , 2005, Cancer research.

[10]  N. Goulden,et al.  Characterization of acute lymphoblastic leukemia progenitor cells. , 2004, Blood.

[11]  M. Wright,et al.  Tetraspanins: molecular organisers of the leukocyte surface. , 2003, Trends in immunology.

[12]  C. Iselin,et al.  Motility‐related protein 1 (MRP‐1/CD9) expression in urothelial bladder carcinoma and its relation to tumor recurrence and progression , 2003, Cancer.

[13]  Irving L. Weissman,et al.  Normal and leukemic hematopoiesis: Are leukemias a stem cell disorder or a reacquisition of stem cell characteristics? , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Mamoru Ito,et al.  Complete reconstitution of human lymphocytes from cord blood CD34+ cells using the NOD/SCID/gammacnull mice model. , 2003, Blood.

[15]  M. Dworzak,et al.  Flow Cytometric Detection of Minimal Residual Disease in Acute Lymphoblastic Leukemia , 2003, Leukemia & lymphoma.

[16]  I. Weissman,et al.  Stem cells, cancer, and cancer stem cells , 2001, Nature.

[17]  D. Howard,et al.  The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells , 2000, Leukemia.

[18]  J. Dick,et al.  Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell , 1997, Nature Medicine.